Katherine Kalin

Katherine Kalin

Director/Board Member at GENFIT

Net worth: 1 M $ as of 31/05/2026

63 year
Health Technology
Finance
Consumer Services

Profile

Katherine Bach Kalin is currently Director at Brown Advisory, Inc. since 2018, Independent Director at Genfit SA since 2020, Independent Director at SELLAS Life Sciences Group, Inc. since 2022, and Trustee at Summit Foundation.
Former roles include Independent Director at Athersys, Inc. from 2020 to 2022, Director at Clinical Genomics Technologies Pty Ltd. from 2018 to 2021, Vice President at Celgene Corp.
from 2012 to 2017, Finance Manager at Nomura International Plc and Nomura International Ltd. from 1984 to 1988, and Partner at Mckinsey & Co. SAS from 1990 to 2002.
Education includes an undergraduate degree from the University of Durham and an MBA from Harvard Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/04/2026 104,400 ( 0.06% ) 971 964 $ 31/05/2026
01/04/2025 5,000 ( 0.01% ) 51 346 $ 31/05/2026

Katherine Kalin active positions

CompaniesPositionStart
GENFIT Director/Board Member 07/07/2020
SELLAS LIFE SCIENCES GROUP, INC. Director/Board Member 13/08/2022
Director/Board Member 01/01/2018
Summit Foundation
Director/Board Member -

Former positions of Katherine Kalin

CompaniesPositionEnd
ATHERSYS, INC. Director/Board Member 16/06/2022
Director/Board Member 01/01/2021
CELGENE Corporate Officer/Principal 01/09/2017
Corporate Officer/Principal 01/01/2002
Director of Finance/CFO 01/01/1988
See the detail of Katherine Kalin's experience

Training of Katherine Kalin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Finance

Finance

Summit Foundation

Consumer Services

Health Technology

Finance

Health Technology

Commercial Services

Consumer Services

Health Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Katherine Kalin